Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialYeming Wang, Chen Wang, Jianping Zhao et al.|The Lancet|2020Cited by 3.7k
Adaptive designs in clinical trials: why use them, and how to run and report themPhilip Pallmann, Thomas Jaki|BMC Medicine|2018Cited by 826